Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT00086463 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension
Ayerza Syndrome
Pulmonary Hypertension

Interventions

DRUG: Iloprost or placebo

Sponsor

Actelion